Proceeds Purposes We are pleased to have attracted such an experienced and knowledgeable syndicate in this financing,” said Dr. Scott Rader, president & CEO of IlluminOss Medical. “We view this financing as both a validation of the revolutionary nature of the core IlluminOss technology, as well as the critical addition of the financial and strategic expertise necessary to help the company rapidly grow and transform how patients’ fractured bones are treated.